Abstract
In medical image classification tasks like the detection of diabetic retinopathy from retinal fundus images, it is highly desirable to get visual explanations for the decisions of black-box deep neural networks (DNNs). However, gradient-based saliency methods often fail to highlight the diseased image regions reliably. On the other hand, adversarially robust models have more interpretable gradients than plain models but suffer typically from a significant drop in accuracy, which is unacceptable for clinical practice. Here, we show that one can get the best of both worlds by ensembling a plain and an adversarially robust model: maintaining high accuracy but having improved visual explanations. Also, our ensemble produces meaningful visual counterfactuals which are complementary to existing saliency-based techniques. Code is available under https://github.com/valentyn1boreiko/Fundus_VCEs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge support by the German Ministry of Science and Education (BMBF, 01GQ1601 and 01IS18039A) and the German Science Foundation \newline (BE5601/8-1 and EXC 2064, project number 390727645). The authors thank the International Max Planck Research School for Intelligent Systems (IMPRS-IS) for supporting I.I.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at: https://www.kaggle.com/c/diabetic-retinopathy-detection https://www.adcis.net/en/third-party/messidor/ https://ieee-dataport.org/open-access/indian-diabetic-retinopathy-image-dataset-idrid https://isbi.deepdr.org/challenge2.html
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at
https://www.kaggle.com/c/diabetic-retinopathy-detection
https://www.adcis.net/en/third-party/messidor/
https://ieee-dataport.org/open-access/indian-diabetic-retinopathy-image-dataset-idrid
